Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

NCT03869775 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2019-03-12

No results posted yet for this study

Summary

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Conditions

  • Anesthesia; Adverse Effect

Interventions

DEVICE

perfusion index monitor

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

DIAGNOSTIC_TEST

ewing test

ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis

Sponsors & Collaborators

  • Erzincan University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-12-01
Completion
2020-12-01
FDA Device
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03869775 on ClinicalTrials.gov